Back

Watch Compare

Bionano Genomics, Inc.

Data quality: 100%

BNGO

Nasdaq Manufacturing Measuring & Analyzing Instruments

$1.15

▼ $0.04 (-2.97%)

Mkt Cap: 12.70 M

Price

$1.15

Mkt Cap

12.70 M

Day Range

$1.14 — $1.19

52-Week Range

$1.06 — $5.50

Volume

100,614

Open $1.19

50D / 200D Avg

$1.19

4.12% below

50D / 200D Avg

$2.11

45.77% below

Quick Summary

Key Takeaways

Revenue grew 12.21% annually over 5 years — strong growth

Negative free cash flow of -16.35 M

Revenue growth is decelerating — 1Y growth trails 5Y average by 19.58%

Growth

Revenue Growth (5Y)

12.21%

Above sector avg (1.82%)

Revenue (1Y)-7.37%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

-55.47%

Below sector avg (-53.41%)

ROIC-48.81%

Net Margin-92.59%

Op. Margin-116.95%

Safety

Debt / Equity

N/A

Current Ratio2.12

Interest CoverageN/A

Valuation

PE (TTM)

-0.48

Above sector avg (-1.48)

P/B Ratio0.26

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	-0.5	-1.5
P/B	0.3	1.6
ROE %	-55.5	-53.4
Net Margin %	-92.6	-41.5
Rev Growth 5Y %	12.2	1.8
D/E	—	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-7.37%	Revenue Growth (3Y)	-11.15%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	12.21%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	28.51 M	Net Income (TTM)	-26.40 M
ROE	-55.47%	ROA	-34.04%
Gross Margin	N/A	Operating Margin	-116.95%
Net Margin	-92.59%	Free Cash Flow (TTM)	-16.35 M
ROIC	-48.81%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	2.12
Interest Coverage	N/A	Asset Turnover	0.37
Working Capital	25.82 M	Tangible Book Value	44.11 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-0.48	Forward P/E	N/A
P/B Ratio	0.26	P/S Ratio	0.45
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-128.70%
Market Cap	12.70 M	Enterprise Value	9.64 M
Per Share
EPS (Diluted TTM)	-4.85	Revenue / Share	2.57
FCF / Share	-1.47	OCF / Share	-1.47
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	61.92%
SBC-Adj. FCF	-22.16 M	Growth Momentum	-19.58

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	28.51 M	30.78 M	36.12 M	27.80 M	17.98 M
Net Income	-26.40 M	-112.02 M	-232.49 M	-132.60 M	-72.44 M
EPS (Diluted)	-4.85	-88.13	-6.81	-0.46	—
Gross Profit	—	—	—	—	—
Operating Income	-33.34 M	-103.98 M	-215.25 M	-131.70 M	-77.10 M
EBITDA	—	—	—	—	—
R&D Expenses	11.37 M	24.80 M	54.03 M	49.05 M	22.49 M
SG&A Expenses	35.15 M	51.86 M	93.50 M	88.60 M	58.49 M
D&A	9.53 M	14.02 M	13.71 M	9.62 M	3.35 M
Interest Expense	—	—	5.12 M	298,000.0	927,000.0
Income Tax	67,000.0	33,000.0	62,000.0	1.88 M	-5.72 M

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	73.58 M	76.67 M	214.40 M	307.50 M	377.10 M
Total Liabilities	29.16 M	41.30 M	118.25 M	58.10 M	39.98 M
Shareholders' Equity	44.42 M	35.38 M	96.16 M	249.40 M	337.12 M
Total Debt	—	—	—	—	16.33 M
Cash & Equivalents	2.99 M	9.17 M	17.95 M	5.09 M	24.57 M
Current Assets	45.39 M	39.49 M	140.12 M	157.30 M	272.41 M
Current Liabilities	22.94 M	37.34 M	100.03 M	35.88 M	21.84 M